A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment

Published:2021-09 Issue: Volume:166 Page:30-43
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Zou Tengteng,Lu Wenping,Mezhuev Yaroslav,Lan Meng,Li Lihong,Liu Fengjie,Cai Tiange,Wu Xiaoyu,Cai Yu

Funder

Guangzhou Science and Technology Program Key Projects

Guangdong Provincial Natural Science Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference165 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Breast cancer statistics, 2019;DeSantis;CA Cancer J. Clin.,2019

3. Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment;Park;Theranostics.,2019

4. Tumor targeting via EPR: Strategies to enhance patient responses;Golombek;Adv. Drug Deliv. Rev.,2018

5. Progress and challenges towards targeted delivery of cancer therapeutics;Rosenblum;Nat. Commun.,2018

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of injectable psoralen polymeric lipid nanoparticles for cancer therapeutics;Arabian Journal of Chemistry;2024-10

2. Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives;Biomedicine & Pharmacotherapy;2024-10

3. Surface Engineering of Magnetic Iron Oxide Nanoparticles for Breast Cancer Diagnostics and Drug Delivery;International Journal of Nanomedicine;2024-08

4. Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy;International Journal of Nanomedicine;2024-06

5. Targeting triple negative breast cancer stem cells using nanocarriers;Discover Nano;2024-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3